Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook

Report Scope:

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

- 28 data tables
- An overview of global markets for stem cell and regenerative medicines
- Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Details of historic background and description of embryonic and adult stem cells
- Information on stem cell banking and stem cell research
- A look at the growing research & development activities in regenerative medicine
- Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals
- Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. and Novartis AG

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview: Cells
Overview: Stem Cell
Embryonic Stem Cell (ES)
Growth and Identification of Embryonic Stem Cells
Stimulating Embryonic Stem Cells to Differentiate
Adult Stem Cell
Mesenchymal Stem Cells
Hematopoietic Stem Cells
Neural Stem Cell
Endothelial Progenitor Cell
Epithelial Stem Cell
Very Small Embryonic-Like Cell
Cord Blood Stem Cell
Induced Pluripotent Stem Cells
Evolution of Induced Pluripotent Stem Cell Research
Advantages
Disadvantages
Cellular Reprogramming in Stem Cells
Human Parthenogenetic Stem Cells
Limitations in Stem Cell and Regenerative Therapy
Cancer Stem Cells
Historic Background of Stem Biology
Stem Cell Research
Stem Cell Research Centers
Stem Cell Production
Stem Cell Acquisition
Characterization and Expansion
Maintenance and Storage
Stem Cell Production Economics
Customized Therapy
Overview: Regenerative Medicine
Chapter 4 Market Dynamics
Market Drivers
Increasing Emphasis on Stem Cell Research
Growing Research and Development Activities in Regenerative Medicine
Rise in Prevalence of Trauma Emergencies and Chronic Diseases
Technological Advancement in Stem Cell Tools and Products
Market Restraints
Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
High Treatment Cost and Operational Inefficiency Associated with Stem Cell Research
Chapter 5 Market Breakdown by Product
Global Stem Cell and Regenerative Medicines Market, by Product
Therapeutic Products
Market Size and Forecast
Cell Therapies
Tissue Engineering
Gene Therapy
Cell Banking
Market Size and Forecast
Market Analysis
Tools and Reagents
Market Size and Forecast
Market Analysis
Chapter 6 Market Breakdown by Application
Global Stem Cell and Regenerative Medicines Market, by Application
Oncology
Market Size and Forecast
Market Analysis
Cardiovascular Disorders
Market Size and Forecast
Market Analysis
Dermatology
Market Size and Forecast
Market Analysis
Orthopedic
Market Size and Forecast
Market Analysis
Central Nervous System Disorders
Market Size and Forecast
Market Analysis
Diabetes
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis
Chapter 7 Market Breakdown by Region
Global Market for Stem Cell and Regenerative Medicines, by Region
North America
United States
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
South America
Middle East and Africa
Chapter 8 Regulatory Scenario
Stem Cell Regulation
Australia
Brazil
Canada
China
France
Germany
India
Ireland
Israel
Italy
Japan
South Korea
Spain
U.K.
U.S.
European Union
Chapter 9 Patent Analysis
Patent Analysis
Tissue Engineering and Regeneration Patent
Japan Patent Analysis
Europe Patent Analysis
U.S. Patent Analysis
Stem Cell Patents
Patentability of Stem Cell Lines
Policies by Country
Chapter 10 Competitive Landscape
Merger and Acquisitions
Merger and Acquisitions in 2019 (Till April 2019)
Merger and Acquisitions in 2018
Merger and Acquisitions in 2017
Partnerships and Collaborations
Product Launches
Chapter 11 Company Profiles
3DMATRIX
ALDAGEN INC.
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
BOEHRINGER INGELHEIM GMBH
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CERAPEDICS INC.
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CRYOLIFE INC.
CYTORI THERAPEUTICS INC.
DAIICHI SANKYO CO. LTD.
EPISTEM LTD.
GAMIDA CELL LTD.
GILEAD SCIENCES INC.
GLOBALSTEM
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORPORATION
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NOVARTIS AG
NUO THERAPEUTICS INC. (CYTOMEDIX INC.)
OCATA
ORGANOGENESIS INC. (ADVANCED BIOHEALING)
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
STEM CELLS INC.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
TIGENIX NV (A PART OF TAKEDA PHARMACEUTICAL COMPANY LIMITED)
U.S. STEM CELL INC.
VERICEL CORPORATION
VERISTEM
VIACYTE INC.
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE
Chapter 12 Appendix: Abbreviations

List Of Tables


Summary Table : Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 1 : Investments in Stem Cell Research
Table 2 : Snapshot of Regenerative Product Pipeline
Table 3 : Ethical Issues in Different Phases of Stem Cell Research
Table 4 : Global Stem Cell and Regenerative Medicines Market, by Product, Through 2024
Table 5 : Global Stem Cell and Regenerative Therapeutic Products Market, byType, Through 2024
Table 6 : Cell-Based Immunotherapy Products
Table 7 : Stem Cells, Advantages and Clinical Trials in Cardiovascular Disease Treatment
Table 8 : Tissue-Engineered Products
Table 9 : Clinical Trials of Rare Diseases, by Technology, 2018
Table 10 : Gene Therapy Products
Table 11 : Recent Developments in the Stem Cell Reagents, 2016-2019
Table 12 : Global Stem Cell and Regenerative Medicines Market, by Application, Through 2024
Table 13 : Cell Therapies by Different Companies to Treat Cardiovascular Diseases
Table 14 : Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
Table 15 : Cellular Skin Tissue-Engineered Products in the Market
Table 16 : Orthopedic Diseases by Region: Key Facts
Table 17 : Demineralized Bone Matrix Products Cleared by FDA
Table 18 : Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 19 : Regenerative Medicine Companies, by Size and Region, 2018
Table 20 : North American Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 21 : European Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 22 : Asia-Pacific Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 23 : Regenerative Medical Products Approved in Japan Since the New Regenerative Medicine Legislation
Table 24 : Japan Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 25 : Europe Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 26 : U.S. Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 27 : Abbreviations Used in This Report

List Of Figures


Summary Figure : Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 1 : Early Development of Embryo
Figure 2 : Global Stem Cell and Regenerative Medicines Market Share, by Product, 2018
Figure 3 : Global Stem Cell and Regenerative Therapeutic Products Market, 2018-2024
Figure 4 : Global Stem Cell and Regenerative Therapeutic Products Market Share, by Type, 2018
Figure 5 : Global Cell Therapy Market, 2018-2024
Figure 6 : Global Tissue Engineering Market, 2018-2024
Figure 7 : Global Prevalence of Diabetes, by Region, 2017
Figure 8 : Global Gene Therapy Market, 2018-2024
Figure 9 : Global Cell Banking Market, 2018-2024
Figure 10 : Global Tools and Reagents Market, 2018-2024
Figure 11 : Global Stem Cell and Regenerative Medicines Market Share, by Application, 2018
Figure 12 : Global Stem Cell and Regenerative Medicines Market for Oncology, 2018-2024
Figure 13 : T-cell Therapy Technique
Figure 14 : Global Segmentation for Cancer Stem Cells Market
Figure 15 : Global Stem Cell and Regenerative Medicines Market for Cardiovascular Disorders, 2018-2024
Figure 16 : Global Stem Cell and Regenerative Medicines Market for Dermatology, 2018-2024
Figure 17 : Global Stem Cell and Regenerative Medicines Market for Orthopedics, 2018-2024
Figure 18 : Global Number of Surgeries, 2012-2020
Figure 19 : Global Stem Cell and Regenerative Medicines Market for Central Nervous System Disorders, 2018-2024
Figure 20 : Global Stem Cell and Regenerative Medicines Market for Diabetes, 2018-2024
Figure 21 : Global Stem Cell and Regenerative Medicines Market for Other Applications, 2018-2024
Figure 22 : Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 23 : Regenerative Medicine Companies, by Size and Region, 2018
Figure 24 : North American Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 25 : U.S. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 26 : Potential U.S. Patient Populations for Cell-Based Therapies, 2016
Figure 27 : NIH Stem Cell Research Spending, 2013-2018
Figure 28 : Canadian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 29 : Mexican Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 30 : European Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 31 : German Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 32 : Health Spending Throughout Germany, by Source, 2015 and 2040 (Est.)
Figure 33 : U.K. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 34 : French Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 35 : Italian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 36 : Spanish Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 37 : Rest of Europe Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 38 : Asia-Pacific Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 39 : Japanese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 40 : Chinese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 41 : Indian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 42 : Rest of Asia-Pacific Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 43 : South American Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 44 : Middle East and African Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 45 : Factors Driving M&A Deals Across the Life Science Sector

Single-use Technologies for Biopharmaceuticals: Global Markets

Single-use Technologies for Biopharmaceuticals: Global Markets market research report available in single user pdf license with Aarkstore Enterprise at USD 5500

USD 5500 View Report

United Therapeutics Nine Months 2021 Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research Report 2021-2025

Autologous stem cell and non-stem cell based therapies is a significant therapeutic intervention that makes use of an individuals cells which are then cultured and reintroduced into the donor patients

USD 3200 View Report

Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Fetal Liver Kinase 2 or CD135 or FLT3 or EC 2.7.10.1) - Drugs in Development, 2021

Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Fetal Liver Kinase 2 or CD135 or FLT3

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available

 

 

FAQs

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.